Sale!

Kaletra (Lopinavir 200mg/Ritonavir 50mg)

A$339.30

-28%
Kaletra contains lopinavir and ritonavir, medicines used to treat HIV-1 infection in adults and children. It works by blocking enzymes the virus needs to multiply. Kaletra may be taken with other HIV medicines as part of a combination treatment. Common side effects can include diarrhoea, nausea, abdominal pain, headache, and increased cholesterol or triglycerides. Take it exactly as directed and store at room temperature.

Kaletra® (Lopinavir 200 mg / Ritonavir 50 mg) — Patient Information (Australia)

Kaletra is a combination antiviral medicine used to treat HIV (Human Immunodeficiency Virus). It contains two active ingredients: lopinavir 200 mg and ritonavir 50 mg in each dose.

This page provides general information about how Kaletra works, how it is usually taken, important food and medicine interactions, safety considerations, and practical tips for everyday use in Australia.


Basic product information

Product Active ingredients Common use
Kaletra® Lopinavir 200 mg + Ritonavir 50 mg Antiretroviral treatment for HIV
  • Medicine type: Protease inhibitor (lopinavir) boosted with ritonavir
  • How it works: Blocks HIV protease, preventing new virus particles from maturing
  • Common forms (availability may vary): Tablets and oral solution

Brand names and formulations can vary. Your pharmacist can confirm the specific product you have.


How Kaletra works (mechanism of action)

HIV needs an enzyme called HIV protease to produce fully mature, infectious virus particles. Lopinavir is a protease inhibitor that binds to the HIV protease enzyme and blocks its activity.

Ritonavir is also an HIV protease inhibitor, but in Kaletra it is mainly used as a “booster”. Ritonavir helps slow down the breakdown of lopinavir in the body (by affecting liver enzymes), so that lopinavir levels stay high enough to suppress HIV effectively.

Together, the medicines reduce viral replication. Over time, this can help reduce the amount of HIV in the body (viral load), maintain or increase immune function, and reduce the risk of HIV-related illness when taken as part of a complete treatment plan.


Pharmacokinetics (how the body handles Kaletra)

“Pharmacokinetics” describes absorption, distribution, metabolism, and elimination. For Kaletra:

  • Absorption: Lopinavir is absorbed from the gut. Food can increase exposure for some formulations.
  • Metabolism: Lopinavir and ritonavir are mainly metabolised by liver enzymes, particularly CYP3A4.
  • Booster effect: Ritonavir inhibits CYP3A4, increasing and stabilising lopinavir concentrations.
  • Elimination: Metabolites are cleared primarily via the liver and then through bile/intestinal pathways.
  • Variability: Drug levels can vary between people. This is one reason interactions with other medicines are important.

Your clinician may monitor your response with blood tests such as viral load and CD4 count. In some settings, drug interaction concerns may prompt additional monitoring.


What Kaletra is typically used for

Kaletra is used as part of combination antiretroviral therapy for HIV infection. The exact regimen depends on factors such as:

  • your treatment history
  • previous HIV resistance testing
  • other medical conditions
  • potential drug–drug interactions
  • pregnancy status (if relevant)

Kaletra is usually used in combination with other HIV medicines to maximise effectiveness and reduce the risk of resistance. It is not used as a single medicine for HIV.


Indications (when Kaletra may be considered)

Kaletra is indicated for treatment of HIV infection in suitable patients as determined by clinical assessment. It may be used in adults and, depending on local guidance and formulation, in children/adolescents.

Because HIV treatment is personalised, selection of Kaletra depends on:

  • previous antiretroviral exposure
  • drug resistance patterns
  • tolerability and safety considerations
  • availability and interactions with current medicines

Dosing and timing (general guidance)

Dosing may vary depending on the specific patient, formulation, and the prescribed treatment plan. Always follow the dosing schedule given by your healthcare professional and the information supplied with your product.

Common adult dosing schedules (may vary):

  • Twice daily regimen: often used where a twice-daily schedule is appropriate.
  • Once daily regimen: some protease inhibitor strategies use once daily approaches; suitability depends on clinical factors.

If you have been prescribed Kaletra tablets or oral solution, the number of tablets or volume per dose will differ by formulation. Your pharmacist can help you confirm your exact dose.

When to take Kaletra

  • Consistency is important: take doses at roughly the same times each day.
  • Missed dose: if you miss a dose, take it when you remember if it is close to the next dose time. Do not take double doses to make up for a missed dose.
  • Adherence: taking HIV medicines regularly helps keep viral load controlled and lowers resistance risk.

Food interactions (take with food—what to know)

Food can affect absorption and blood levels of lopinavir. In practice:

  • Tablets/oral formulations: the product instructions may specify whether to take with food and what type of meal. Some formulations require taking with food to improve absorption.
  • Try to be consistent: if your regimen is “with food,” keep the habit steady (e.g., take with a meal each time).

If you are unsure whether your specific Kaletra product should be taken with food, check the packaging or ask your pharmacist.


Alcohol and medicine interactions

Alcohol

Alcohol may affect how you feel and can impact liver function. Since Kaletra is metabolised by the liver and may interact with multiple medications, it is advisable to:

  • limit alcohol intake
  • discuss your alcohol use with your healthcare professional, especially if you have liver disease

For the oral solution, note that certain liquid medicines may contain alcohol or propylene glycol. Check the product label and ask your pharmacist if alcohol content is a concern for you.

Important medicine interactions

Kaletra has major potential drug–drug interactions. This is because ritonavir strongly influences liver enzymes that process many medicines. Some medicines can significantly reduce Kaletra levels (making it less effective), while others can increase levels (raising the risk of side effects).

Tell your healthcare professional about all medicines you take, including:

  • prescription medicines
  • over-the-counter medicines (e.g., cold/flu products)
  • herbal supplements (e.g., St John’s wort)
  • antacids and acid-suppressing medicines
  • vitamins or minerals
  • recreational substances (for safety reasons)

Common interaction themes to be aware of:

  • Antidepressants/antipsychotics and some antiarrhythmics may have interaction risks.
  • Anticonvulsants can alter enzyme activity and affect drug levels.
  • Antifungals and antibiotics can change lopinavir/ritonavir exposure.
  • Statins and other lipid-lowering medicines require careful selection and monitoring.
  • Hormonal contraceptives: interactions may affect contraceptive reliability for some regimens.
  • Herbal products (e.g., St John’s wort): generally avoided because they can reduce antiretroviral effectiveness.

If you are starting any new medicine, always ask whether it interacts with Kaletra. Pharmacists are well placed to help check interaction risk.


Safety profile (what to watch for)

Like all medicines, Kaletra can cause side effects. Many people tolerate treatment well, but some adverse effects require prompt attention.

Common side effects

  • Gastrointestinal symptoms: diarrhoea, nausea, vomiting, abdominal discomfort
  • Headache or dizziness
  • Fatigue
  • Changes in blood fats: increased cholesterol and triglycerides
  • Blood sugar changes: possible increase in glucose (especially in people with diabetes risk)

Less common but important risks

  • Liver effects: hepatitis-like symptoms or elevated liver enzymes may occur. Seek medical advice if you develop yellowing of the eyes/skin, dark urine, or severe fatigue.
  • Heart rhythm effects: in some cases, protease inhibitors can contribute to QT-related risks when combined with other interacting medicines.
  • Immune reconstitution: when HIV responds to treatment, inflammatory responses can occur in some patients.
  • Pancreatitis: rare, but seek urgent care if severe upper abdominal pain occurs.
  • Allergic reactions: seek urgent care for swelling, rash with breathing difficulty, or severe skin reactions.

Blood test monitoring

Clinicians commonly monitor:

  • Liver function (ALT/AST, bilirubin)
  • Fasting lipids (cholesterol, triglycerides)
  • Glucose (especially if diabetes risk)
  • Full blood count as appropriate
  • HIV viral load and CD4 count

If you experience symptoms between appointments, contact your healthcare provider promptly.


Practical use tips (making Kaletra easier to take)

  • Plan your routine: link doses to meals or your daily schedule to improve adherence.
  • Use reminders: phone alarms or pill organisers can help avoid missed doses.
  • Hydration and GI comfort: if diarrhoea occurs, stay hydrated and talk to your pharmacist/doctor. Don’t stop treatment without advice.
  • Keep a medication list: carry a list of your medicines (including supplements) for interaction checks.
  • Storage: store at room temperature as directed on the packaging; protect from excessive heat and moisture.
  • Handling oral solution: shake the bottle if instructed, measure carefully using the provided dosing device, and follow storage instructions.

Managing missed doses

If you miss a dose, refer to the instructions you received with your medicine. In general:

  • take it when you remember if it is near the time of the next dose,
  • but do not take double doses to catch up.

If you repeatedly miss doses, speak with your healthcare professional to adjust the regimen where possible.


Recent guidance and clinical context (Australia)

HIV treatment recommendations in Australia are updated periodically by expert groups and health authorities. While Kaletra is an established protease inhibitor/boosted regimen, many patients are guided toward regimens that best match effectiveness, tolerability, resistance history, and interaction profile.

Recent practice commonly emphasises:

  • Combination antiretroviral therapy with appropriate monitoring
  • Resistance-aware selection of medicines
  • Careful interaction screening due to ritonavir’s enzyme effects
  • Regular blood tests to monitor liver function, lipids, glucose, and HIV markers

If you’re already taking Kaletra, it’s important not to stop or switch without medical guidance—changing regimens can affect viral control.


Alternative options

Several antiretroviral classes are available, and the “best” option depends on your individual situation. Alternatives may include other protease inhibitors, NNRTIs, integrase inhibitors, or combination fixed-dose regimens.

Examples of alternative approaches (categories only):

  • Other boosted protease inhibitor regimens (if appropriate and suitable)
  • Integrase-based regimens (often preferred for simplicity and interaction profiles in some patients)
  • Single-tablet regimens (where clinically appropriate)

If you are considering a change, ask about:

  • resistance history
  • interaction risks with your current medications
  • side effect profile and monitoring needs
  • dose frequency and quality-of-life factors


Market and legal context in Australia (overview)

In Australia, antiretroviral medicines are regulated as prescription medicines through the Therapeutic Goods Administration (TGA) and dispensed in line with Australian healthcare requirements. Availability through online pharmacies depends on product listing status, supply chain, and the pharmacy’s services.

Some HIV medicines may be available under specific pathways or schemes to support continuity of care. Requirements may vary depending on your location and the pharmacy’s processes.

If you’re purchasing online, ensure you select a legitimate Australian-licensed pharmacy and verify:

  • the medicine name and strength match your prescribed regimen
  • the formulation type (tablets vs oral solution)
  • expiry date and packaging condition
  • safe delivery and storage instructions

Delivery and availability (what to expect online)

Availability may vary by region and stock levels. When ordering online in Australia:

  • Check product form: tablets vs oral solution
  • Allow delivery time: processing and courier times differ between pharmacies
  • Temperature considerations: most antiretroviral tablets are stable at normal room temperature; follow the storage directions on the pack
  • Follow packaging instructions: keep in original packaging until use

If a product is temporarily unavailable, the pharmacy may offer an expected restock date or an alternative formulation where clinically appropriate.


FAQ

1) What is Kaletra used for?

Kaletra is used as part of HIV treatment to suppress HIV when combined with other antiretroviral medicines as directed by your healthcare team.

2) How soon does Kaletra start working?

Many people see viral load reductions over weeks to months, but the timing varies. Your clinician will monitor response with blood tests such as viral load and CD4 count.

3) Should I take Kaletra with food?

Food can affect absorption. The product instructions may specify taking with food. For best results, follow the instructions provided for your specific Kaletra formulation and keep the routine consistent.

4) Can I drink alcohol while taking Kaletra?

Alcohol may increase the risk of liver strain and can worsen side effects for some people. It’s best to discuss your level of alcohol use with your healthcare professional. If you’re using the oral solution, check whether it contains alcohol and ask your pharmacist if relevant.

5) What medicines commonly interact with Kaletra?

Many medicines can interact due to ritonavir’s effects on liver enzymes. Always check before starting new medications, including over-the-counter and herbal products. In particular, avoid herbal supplements such as St John’s wort unless your healthcare professional says otherwise.

6) What should I do if I miss a dose?

If you miss a dose, take it when you remember if it is near your next dose time. Do not take double doses to catch up. If you’re unsure, ask your pharmacist for advice.

7) What side effects should make me seek urgent help?

Seek urgent medical care if you experience:

  • signs of severe allergic reaction (swelling, trouble breathing, widespread rash)
  • severe abdominal pain (possible pancreatitis)
  • yellowing of the skin/eyes or dark urine (possible liver problem)
  • fainting, severe dizziness, or new severe heart symptoms

8) How are liver and cholesterol monitored?

Clinicians commonly perform periodic blood tests to monitor liver enzymes and fasting lipids (cholesterol/triglycerides), and sometimes glucose levels, especially in people at risk for metabolic complications.

9) Are there alternatives if I cannot tolerate Kaletra?

Yes. Alternatives exist within different antiretroviral classes. The best choice depends on your HIV history, resistance testing, side effects, and interaction profile. Speak with your healthcare provider about switching options.

10) Is Kaletra available for delivery in Australia?

Many online pharmacies can deliver to Australian addresses, subject to availability and pharmacy policies. Availability depends on stock and the specific formulation (tablets vs oral solution). Check the product listing and delivery options at checkout.


Important reminder

This information is for general educational purposes and cannot replace personalised medical advice. If you have questions about Kaletra—especially interactions, dosing schedule, or side effects—speak with a pharmacist or healthcare professional.

Additional information

Dosage: No selection

60tab

Package: No selection

1 bottle, 2 bottle, 3 bottle